With Treatment
Nih/nida Archway is treatment center located at 251 Bayview Boulevard, Brc, Suite 200, Room 01b612 in the 21224 zip code in Baltimore, MD that offers medication assisted substance abuse treatment. Nih/nida Archway provides buprenorphine maintenance and suboxone prescription to adults and young adults. Some of the treatment approaches used by Nih/nida Archway consist of motivational interviewing, substance use counseling and cognitive behavioral therapy.
Address: 251 Bayview Boulevard, BRC, Suite 200, Room 01B612, Baltimore, MD 21224
Here are the full facility listing details on NIH/NIDA Archway in Baltimore, MD:
Types of Care at Nih/nida Archway
Service Settings at Nih/nida Archway
Opioid Medications used in Treatment at Nih/nida Archway
Type of Alcohol Use Disorder Treatment at Nih/nida Archway
Type Of Treatment at Nih/nida Archway
Pharmacotherapies at Nih/nida Archway
Treatment Approaches at Nih/nida Archway
Payment/Insurance/Funding Accepted at Nih/nida Archway
Payment Assistance Available at Nih/nida Archway
Assessment/Pre-treatment at Nih/nida Archway
Screening & Testing at Nih/nida Archway
Transitional Services at Nih/nida Archway
Ancillary Services at Nih/nida Archway
Counseling Services and Education at Nih/nida Archway
Tobacco/Screening Services at Nih/nida Archway
Facility Smoking Policy at Nih/nida Archway
Age Groups Accepted at Nih/nida Archway
Gender Accepted at Nih/nida Archway
Exclusive Services at Nih/nida Archway
Phone #: 443-740-2335
Call (866) 434-2077 for 24/7 help with treatment.
Methadone treatment can be a safe and effective option for individuals struggling with opioid addiction, especially when administered under the supervision of a qualified healthcare provider as part of a comprehensive addiction treatment program, such as the one that can be found at NIH/NIDA Archway. Methadone is an opioid medication that is used to help manage opioid withdrawal symptoms and cravings, making it easier for individuals to reduce or quit their use of other opioids like heroin or prescription painkillers.
Here are some key points to consider regarding the safety of methadone treatment:
Supervised Administration: Methadone treatment is typically provided through opioid treatment programs (OTPs) or clinics where patients receive a daily dose of methadone under the supervision of healthcare professionals. This helps reduce the risk of misuse and overdose.
Reduces Withdrawal Symptoms: Methadone can alleviate the severe withdrawal symptoms associated with opioids, which can be a significant barrier to recovery. This can enhance the patient's quality of life and make it easier for them to engage in therapy and counseling.
Harm Reduction: Methadone maintenance treatment can be viewed as a harm reduction approach. While it doesn't necessarily lead to immediate abstinence, it reduces the risks associated with illicit opioid use, such as overdose and the transmission of infectious diseases (e.g., HIV and hepatitis).
Individualized Treatment: Methadone treatment should be individualized to meet the unique needs of each patient. The dose is typically adjusted based on the patient's response and progress in treatment.
Legal Regulation: Methadone clinics and providers are subject to strict regulations and oversight by government agencies to ensure safety and appropriate use of the medication.
However, it's important to note that methadone is an opioid itself and can be habit-forming. When taken as prescribed and under medical supervision, the risk of addiction to methadone is relatively low. However, misuse or diversion of methadone can lead to addiction and other negative consequences.
Methadone treatment is not suitable for everyone. Individuals with certain medical conditions or contraindications may not be candidates for methadone treatment. It's essential for addiction treatment centers like NIH/NIDA Archway to conduct a thorough assessment before starting someone on methadone.
Other drug and rehab centers within 75 miles of NIH/NIDA Archway: